JAZZ
Jazz Pharmaceuticals plc
Next earnings Aug 3, 2026 · consensus $6.30 EPS, $1.13B rev
Last earnings +2.0% on 2026-05-05
$226.20
▼ -1.59%$226.20▲ +110.40%
over 1Y
L $105.93EODHDH $240.06
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-1.6%
1W+0.7%
1M-4.7%
3M+19.6%
YTD+30.6%
1Y+110.4%
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 25 analysts
Buy
Jazz's rare-disease engine still threw off $1.36B of cash on growing sales, but a GAAP net loss and $5.4B of debt keep this a show-me story.
Sources: SEC EDGAR (CIK 0001232524, latest 10-Q filed 2026-05-05) · EODHD · analysis by claude-code · as of 6/21/2026, 8:46:34 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.